L-Arginin 13C6 15N4 Monohydrochlorid, min. 98 % 13C 15N, 100 mg, Glasverpackung

1-(3-Fluoro-5-methylbenzyl)piperidin-4-amine dihydrochloride, 95.0%, 1g

2-Aminoheptanedioic acid, 95.0%, 25g

(3,4-Dihydro-1H-isoquinolin-2-yl)-acetic acid hydrochloride, 95.0%, 5g

4-Bromo-2-iodo-7-azaindole, 95.0%, 1g

4-Bromo-4'-(4-bromophenyl)-3',5',6'-triphenyl-1,1':2',1''-terphenyl, 98%, 1g

5-(2,4-Dichloro-phenyl)-1-methyl-1H-pyrazole-3-carboxylic acid ethyl ester, 95%+, 1g

Methyl propargyl ether, 98.0%, 5g

N,N-Dimethylformamide [for Spectrophotometry]>99.5%(GC)100mL

1-BENZYL 4-METHYL 2-((TERT-BUTOXYCARBONYL)AMINO)SUCCINATE, 97%, 250mg

Overall V9TCI Größe XXXL

(3-Oxo-1,2,3,4-tetrahydro-quinoxalin-2-yl)-acetic acid, 95.0%, 1g

5-Isopropyl-1-(pyridin-2-yl)-1h-pyrazole-3-carboxylic acid, 95%, 250mg